CN Patent

CN110198716A — 癌症治疗

Assigned to Janssen Pharmaceutica NV · Expires 2019-09-03 · 7y expired

What this patent protects

本发明提供用厄达替尼治疗癌症的方法。

USPTO Abstract

本发明提供用厄达替尼治疗癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110198716A
Jurisdiction
CN
Classification
—
Expires
2019-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.